PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
10.19%
Revenue growth exceeding 1.5x ORCL's 6.77%. David Dodd would verify if faster growth reflects superior business model.
-2.17%
Cost reduction while ORCL shows 10.78% growth. Joel Greenblatt would examine competitive advantage.
11.91%
Gross profit growth exceeding 1.5x ORCL's 5.76%. David Dodd would verify competitive advantages.
1.56%
Margin expansion while ORCL shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.20%
Operating expenses growth above 1.5x ORCL's 3.27%. Michael Burry would check for inefficiency.
7.00%
Total costs growth 1.25-1.5x ORCL's 5.16%. Martin Whitman would scrutinize control.
No Data
No Data available this quarter, please select a different quarter.
55.32%
D&A growth above 1.5x ORCL's 5.53%. Michael Burry would check for excessive investment.
19.70%
EBITDA growth exceeding 1.5x ORCL's 11.43%. David Dodd would verify competitive advantages.
34.58%
EBITDA margin growth exceeding 1.5x ORCL's 4.21%. David Dodd would verify competitive advantages.
15.66%
Operating income growth 1.25-1.5x ORCL's 13.06%. Bruce Berkowitz would examine sustainability.
4.97%
Similar operating margin growth to ORCL's 5.89%. Walter Schloss would investigate industry trends.
-526.09%
Other expenses reduction while ORCL shows 0.00% growth. Joel Greenblatt would examine advantage.
-12.79%
Pre-tax income decline while ORCL shows 13.28% growth. Joel Greenblatt would examine position.
-20.85%
Pre-tax margin decline while ORCL shows 6.10% growth. Joel Greenblatt would examine position.
-15.44%
Tax expense reduction while ORCL shows 15.44% growth. Joel Greenblatt would examine advantage.
-11.42%
Net income decline while ORCL shows 12.24% growth. Joel Greenblatt would examine position.
-19.61%
Net margin decline while ORCL shows 5.12% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-11.42%
Both companies reducing share counts. Martin Whitman would check patterns.
-11.42%
Both companies reducing diluted shares. Martin Whitman would check patterns.